These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 16930358

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE, Benbadis S, Edrich P, Tassinari CA, Hirsch E.
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG, Berkovic SF, Black AB, Danta G, Hiersemenzel R, Schapel GJ, Vajda FJ.
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Levetiracetam. A review of its adjunctive use in the management of partial onset seizures.
    Dooley M, Plosker GL.
    Drugs; 2000 Oct; 60(4):871-93. PubMed ID: 11085199
    [Abstract] [Full Text] [Related]

  • 11. Levetiracetam: a new therapeutic option for refractory epilepsy.
    Pinto A, Sander JW.
    Int J Clin Pract; 2003 Sep; 57(7):616-21. PubMed ID: 14529064
    [Abstract] [Full Text] [Related]

  • 12. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY, Hong Z, Wu X, Wu LW, Wang XF, Zhou D, Zhao ZX, Lv CZ.
    Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM, Mintz M, Hunter SJ, Yang H, Jones J, N01103 Levetiracetam Study Group.
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [Abstract] [Full Text] [Related]

  • 17. Effect of levetiracetam in patients with epilepsy and interictal epileptiform discharges.
    Stodieck S, Steinhoff BJ, Kolmsee S, van Rijckevorsel K.
    Seizure; 2001 Dec; 10(8):583-7. PubMed ID: 11792161
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.